These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 460449)

  • 21. [Combination drug therapy in leprosy].
    Terencio de las Aguas J
    Acta Leprol; 1983; 1(3):143-50. PubMed ID: 6359802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anabolic steroid as an adjuvant in the treatment of chronic lepra reaction and ENL under corticosteroid therapy.
    Choudhury S; Kundu S; Ghosh S; Hazra S
    Lepr Rev; 1977 Sep; 48(3):181-4. PubMed ID: 904425
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug resistance and multi-drug therapy in leprosy.
    Chatterjee BR
    Lepr India; 1982 Jul; 54(3):402-11. PubMed ID: 6757576
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immuno-allergic accidents with rifamipcin].
    Flageul B; Wagner L; Cottenot F
    Acta Leprol; 2001-2002; 12(2):71-8. PubMed ID: 12136739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The future of leprosy in the Dominican Republic: experience with multidrug therapy.
    Martinez Cruz D
    Lepr Rev; 1986; 57 Suppl 3():127-33. PubMed ID: 3573953
    [No Abstract]   [Full Text] [Related]  

  • 26. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
    Groenen G; Janssens L; Kayembe T; Nollet E; Coussens L; Pattyn SR
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New developments in the chemotherapy of leprosy.
    Freerksen E
    Lepr India; 1983 Jan; 55(1):122-32. PubMed ID: 6348410
    [No Abstract]   [Full Text] [Related]  

  • 29. Deep vein thrombosis: a rare complication of thalidomide therapy in recurrent erythema nodosum leprosum.
    Sharma NL; Sharma V; Shanker V; Mahajan VK; Sarin S
    Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):483-5. PubMed ID: 15755204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy of leprosy; "bubble" or "calendar" packs for the administration of rifampin, dapsone, clofazimine, or prothionamide/ethionamide.
    Winsley BE; McDougall AC; Brown KE
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):592-4. PubMed ID: 6686974
    [No Abstract]   [Full Text] [Related]  

  • 31. [New WHO recommendations for the treatment of leprosy].
    Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
    [No Abstract]   [Full Text] [Related]  

  • 32. Multi-drug therapy in leprosy.
    Girdhar BK
    Indian J Lepr; 1987; 59(2):145-51. PubMed ID: 3309084
    [No Abstract]   [Full Text] [Related]  

  • 33. The Kellersberger memorial lecture, 1984. Chemotherapy of leprosy--a tool for leprosy control.
    Levy L
    Ethiop Med J; 1985 Jan; 23(1):31-42. PubMed ID: 3965285
    [No Abstract]   [Full Text] [Related]  

  • 34. [Drug resistance of Mycobacterium leprae].
    Pattyn SR
    Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
    [No Abstract]   [Full Text] [Related]  

  • 35. [An imported disease; a nearly missed diagnosis].
    Naafs B; van Joost T; Hausman R; van der Heide RM; de Vet BJ
    Ned Tijdschr Geneeskd; 1982 Oct; 126(42):1897-901. PubMed ID: 6216414
    [No Abstract]   [Full Text] [Related]  

  • 36. Azathioprine in controlling type 2 reactions in leprosy: a case report.
    Athreya SP
    Lepr Rev; 2007 Sep; 78(3):290-2. PubMed ID: 18035780
    [No Abstract]   [Full Text] [Related]  

  • 37. Oral zinc in recurrent Erythema Nodosum Leprosum reaction.
    Mathur NK; Bumb RA; Mangal HN
    Lepr India; 1983 Jul; 55(3):547-52. PubMed ID: 6656212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concepts behind the development of multiple drug therapy regimens in leprosy.
    Waters MF
    Ethiop Med J; 1986 Dec; 24 Suppl 1():61-7. PubMed ID: 3301333
    [No Abstract]   [Full Text] [Related]  

  • 39. Metabolic, pharmacokinetic, and toxicological issues surrounding dapsone.
    Molinelli E; Paolinelli M; Campanati A; Brisigotti V; Offidani A
    Expert Opin Drug Metab Toxicol; 2019 May; 15(5):367-379. PubMed ID: 30943794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Hansen's disease.
    Trautman JR
    Cutis; 1976 Jul; 18(1):62-5. PubMed ID: 1017285
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.